Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells

Amy K. Banes-Berceli, Sean Shaw, Guochuan Ma, Michael Brands, Douglas C. Eaton, David M. Stern, David Fulton, R. William Caldwell, Mario B. Marrero

Research output: Contribution to journalArticle

49 Scopus citations

Abstract

In the current study, we investigated the effect of simvastatin on the ability of high glucose (HG) and ANG II to activate the JAK2-STAT signaling cascade and induce glomerular mesangial cell (GMC) growth. We found that pretreatment with simvastatin significantly inhibited HG- and ANG II-induced collagen IV production, JAK2 activation, and phosphorylation of STAT1 and STAT3 in GMC. We also found that the activation of JAK2 by HG and ANG II was dependent on the Rho family of GTPases. Consistent with these in vitro results, both albumin protein excretion and phosphorylation of JAK2, STAT1, and STAT3 were attenuated in renal glomeruli by administration of simvastatin in a streptozotocin-induced rat model of HG diabetes. This study demonstrates that simvastatin blocks ANG II-induced activation of the JAK/STAT pathway in the diabetic environment, in vitro and in vivo, and, thereby, provides new insights into the molecular mechanisms underlying early diabetic nephropathy.

Original languageEnglish (US)
Pages (from-to)F116-F121
JournalAmerican Journal of Physiology - Renal Physiology
Volume291
Issue number1
DOIs
StatePublished - Jun 30 2006

Keywords

  • Diabetes
  • Nephropathy
  • Rho GTPase

ASJC Scopus subject areas

  • Physiology
  • Urology

Fingerprint Dive into the research topics of 'Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells'. Together they form a unique fingerprint.

  • Cite this